Viyash Scientific Limited operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally. The company provides active pharmaceutical ingredients, finished dosage formulations, analytical services, and VET formulation services for cattle and poultry. The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026.
Viyash Scientific Limited (VIYASH) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The VIYASH share price is ₹234.67 (+0.68% today), with a market capitalisation of ₹104B and a price-to-earnings (P/E) ratio of 57.4. MarketRipple tracks the VIYASH investment thesis, the ripple-chain impact of market events on Viyash Scientific Limited, and the Healthcare sector outlook.
Open
₹231.80
High
₹235.70
Low
₹229.98
Prev. Close
₹233.09
52W High
₹298.00
52W Low
₹178.13
Day range
₹229.98–₹235.70
52-week range
₹178.13–₹298.00
Volume
498K
P/E
57.4
ROE
6.1%
D/E
0.17
Margin
5.9%
Viyash Scientific Limited (NSE: VIYASH) is currently trading at ₹234.67 (+0.68%).
Viyash Scientific Limited's market capitalization is ₹104B.
Viyash Scientific Limited's price-to-earnings (P/E) ratio is 57.4.
Viyash Scientific Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Viyash Scientific Limited currently reads neutral, based on 4 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.